Form D — EIKONOKLASTES THERAPEUTICS, INC.
0001805698-25-000002 · filed Jul 29, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $15,764,780
- Reported amount sold
- $13,555,109
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- EIKONOKLASTES THERAPEUTICS, INC.
- CIK
- 1805698
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2356 PARK AVENUE
CINCINNATI, Ohio 45206 - Phone
- (513) 549-6484
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Bruce Halpryn · Executive OfficerCincinnati, Ohio Find on LinkedIn ↗
-
Samuel Lee · Executive OfficerCincinnati, Ohio Find on LinkedIn ↗
-
Kenneth Morand · DirectorCincinnati, Ohio Find on LinkedIn ↗
-
Thomas Finn · DirectorCincinnati, Ohio Find on LinkedIn ↗
-
Robert Johnson · DirectorCincinnati, Ohio Find on LinkedIn ↗
-
Joseph Nolan · DirectorCincinnati, Ohio Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗